Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 38 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

11%

4 trials in Phase 3/4

Results Transparency

13%

2 of 15 completed with results

Key Signals

2 with results100% success

Data Visualizations

Phase Distribution

38Total
Not Applicable (28)
Early P 1 (1)
P 1 (3)
P 2 (2)
P 3 (2)
P 4 (2)

Trial Status

Completed15
Recruiting9
Not Yet Recruiting6
Unknown5
Active Not Recruiting1
Enrolling By Invitation1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 15 completed trials

Clinical Trials (38)

Showing 20 of 20 trials
NCT03474718Early Phase 1Not Yet RecruitingPrimary

Evaluating the Efficacy of Platelet-rich Plasma Therapy in the Treatment of Androgenic Alopecia

NCT06551818Not ApplicableCompletedPrimary

A Clinical Study to Assess Safety, Efficacy and In-use Tolerability of Different Dosages of Hair Growth Products in Patients With Mild to Moderate Androgenic Alopecia (Grade I to III).

NCT07637071Not ApplicableNot Yet RecruitingPrimary

Study to Evaluate Xtressé Gummy Supplement in Men With Androgenic Alopecia

NCT07588243Not ApplicableRecruitingPrimary

A Clinical Study to Evaluate the Efficacy and Safety of Ultra in Promoting Hair Regrowth

NCT07580521Not ApplicableNot Yet RecruitingPrimary

Microneedling for Androgenic Alopecia: a Clinical Study

NCT07563036Not ApplicableRecruiting

JAK2 Expression in Androgenetic Alopecia Before and After Topical Minoxidil

NCT07502976Not ApplicableRecruitingPrimary

Topical 2-Deoxy-D-ribose Hydrogel Versus Minoxidil 5% Solution for Androgenetic Alopecia

NCT07435012Phase 3RecruitingPrimary

Androgenic Alopecia TH07 Clinical Trial

NCT07107841Not ApplicableRecruitingPrimary

Autologous Hair Follicle Secretome for Androgenic Alopecia (Single Site)

NCT07373054Not ApplicableRecruitingPrimary

Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Androgenic Alopecia

NCT07348315Phase 2CompletedPrimary

Effectiveness of Apheresis Platelet-Rich Plasma Injection for Androgenic Alopecia

NCT07287579Not ApplicableNot Yet RecruitingPrimary

Comparison Between Platelet Rich Plasma and Nanofat as an Adjuvant Therapy in HairTransplantation

NCT07273799Phase 3Not Yet RecruitingPrimary

Comparison of Outcomes Between Topical Minoxidil Versus Oral Minoxidil for the Treatment of Androgenetic Alopecia

NCT07203599Phase 1RecruitingPrimary

A Study on the Treatment of Androgenetic Alopecia in Young Men With Umbilical Cord Mesenchymal Stem Cell Exosomes

NCT06556056Not ApplicableCompletedPrimary

An Exploratory Clinical Study to Assess Safety, Efficacy and In-Use Tolerability of Three Different Hair Growth Products in Patients With Mild to Moderate Androgenic Alopecia (Grade I to III)

NCT05426629Phase 4WithdrawnPrimary

Hydraderm for Androgenic Alopecia

NCT06292533Not ApplicableEnrolling By InvitationPrimary

Effectiveness of Ultrapulse for the Treatment of Androgenic Alopecia Among Malaysian: A Quasi-experimental Study

NCT06697080Not ApplicableActive Not RecruitingPrimary

Umbilical Cord-derived Mesenchymal Stem Cell Exosomes on Hair Growth in Patients With Androgenetic Alopecia

NCT06576492Not ApplicableCompletedPrimary

Assessment of the Effects and Tolerance of the RV4986A Lotion in Men With AGA After Hair Transplant

NCT05938569Not ApplicableRecruitingPrimary

Computer-Assisted Hair Restoration Study Using ARTAS System

Scroll to load more

Research Network

Activity Timeline